Clinical Trial Update: Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a microneedle array delivering doxorubicin for cutaneous squamous cell carcinoma, and the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Falo, Louis, MD | Conditions: Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING